Position in MRK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$920,959
+$133,782 QoQ
Shares Held
7,167
+9.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#2,189
of 3,769 holders
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Simplify Asset Management Inc. holds $101,858,817 across 8 Drug Manufacturers - General names. MRK ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVO |
Novo Nordisk A S
|
504,918 | $24,205,768 | |
| 2 | JNJ |
Johnson & Johnson
|
72,879 | $18,509,079 | |
| 3 | LLY |
ELI LILLY & Co
|
14,715 | $17,649,613 | |
| 4 | ABBV |
AbbVie Inc.
|
64,461 | $16,220,966 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
81,325 | $10,274,600 | |
| 6 | AMGN |
Amgen Inc
|
20,974 | $7,595,104 | |
| 7 | AZN |
Astrazeneca PLC
|
34,188 | $6,482,728 | |
| 8 | MRK |
Merck & Co., Inc.
This page
|
7,167 | $920,959 |
All Filings in MRK
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $920,959 | 7,167 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $787,177 | 6,544 | Shares | Sole | 2026-04-27 | |
| 2024-06-30 | $6,351,187 | 51,302 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $6,289,132 | 47,663 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,419,044 | 22,189 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,934,121 | 18,787 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $438,135 | 3,797 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $303,317 | 2,851 | Shares | Sole | 2023-05-10 | |
| No filing history on record for this holder in this stock. | ||||||